Search Database
Select Protein (1 found)
| UniProt ID | Gene Symbol | Protein Name | Organism | Length | Action |
|---|---|---|---|---|---|
| B4E2T8 | CANX | Calnexin (IP90) (Major histocompatibility complex … | Homo sapiens (Human) | 592 aa |
Protein Details: B4E2T8 (CANX)
Protein Information
| Accession | B4E2T8 |
|---|---|
| Protein Names | Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90) |
| Gene Symbol | CANX |
| Organism | Homo sapiens (Human) |
| Length | 592 aa |
| Isoforms | No isoforms |
| Related PMIDs | 31251020 32651440 |
| Database Sources | No database sources |
These studies detected palmitoylation of this protein in the samples.
Protein Sequence
Types:
Experimental Database High Prediction Non-palmitylated Cys
Experimental Database High Prediction Non-palmitylated Cys
1-501MEGKWLLCML11LVLGTAIVEA21HDGHDDDVID31IEDDLDDVIE41EVEDSKPDTT
51-10051APPSSPKVTY61KAPVPTGEVY71FADSFDRGTL81SGWILSKAKK91DDTDDEIAKY
101-150101DGKWEVEEMK111ESKLPGDKGL121VLMSRAKHHA131ISAKLNKPFL141FDTKPLIVQY
151-200151EVNFQNGIEC161GGAYVKLLSK171TPELNLDQFH181DKTPYTIMFG191PDKCGEDYKL
201-250201HFIFRHKNPK211TGIYEEKHAK221RPDADLKTYF231TDKKTHLYTL241ILNPDNSFEI
251-300251LVDQSVVNSG261NLLNDMTPPV271NPSREIEDPE281DRKPEDWDER291PKIPDPEAVK
301-350301PDDWDEDAPA311KIPDEEATKP321EGWLDDEPEY331VPDPDAEKPE341DWDEDMDGEW
351-400351EAPQIANPRC361ESAPGCGVWQ371RPVIDNPNYK381GKWKPPMIDN391PSYQGIWKPR
401-450401KIPNPDFFED411LEPFRMTPFS421AIGLELWSMT431SDIFFDNFII441CADRRIVDDW
451-500451ANDGWGLKKA461ADGAAEPGVV471GQMIEAAEER481PWLWVVYILT491VALPVFLVIL
501-550501FCCSGKKQTS511GMEYKKTDAP521QPDVKEEEEE531KEEEKDKGDE541EEEGEEKLEE
551-592551KQKSDAEEDG561GTVSQEEEDR571KPKAEEDEIL581NRSPRNRKPR591RE
Palmitoylation Sites Details
| Position | Database | Domains | Literature (PMID/Cell-Tissue) | Mass(PMID/Cell-Tissue) | Prediction Scores |
|---|---|---|---|---|---|
| 8 | - | - | - |
Deep-Palm: 0.05
|
|
| 160 | - | - | - |
Deep-Palm: 0.45
|
|
| 194 | - | - | - |
Deep-Palm: 0.12
|
|
| 360 | - | - | - |
Deep-Palm: 0.14
|
|
| 366 | - | - | - |
Deep-Palm: 0.35
|
|
| 441 | - | - | - |
Deep-Palm: 0.05
|
|
| 502 | - | - | - |
Deep-Palm: 0.96
|
|
| 503 | - | - | - |
Deep-Palm: 0.96
|
Score Interpretation:
• GPS-Palm: Thresholds - High (≥0.8920), Medium (≥0.7766), Low (≥0.6484), Very Low (<0.6484)
• Deep-Palm: Higher score indicates higher probability of palmitoylation (High ≥0.9)
• GPS-Palm: Thresholds - High (≥0.8920), Medium (≥0.7766), Low (≥0.6484), Very Low (<0.6484)
• Deep-Palm: Higher score indicates higher probability of palmitoylation (High ≥0.9)
Tissue/Cell Line Expression
Literature Data - Tissue/Cell Line Expression
Tissue Specificity Index (TSI): 0.500
1
LNCaP
Specificity: 0.500
1/1 (100.0%)
1
Jurkat T cell
Specificity: 0.500
1/1 (100.0%)
Mass Spectrometry Data - Tissue/Cell Line Expression
Tissue Specificity Index (TSI): 0.000Palmitoylation Distribution by Study and Tissue/Cell Line
Chart Explanation: Each bar represents a study (PMID).
Blue bars: Literature data, Orange bars: Mass Spectrometry data.
The colored bottom segment shows palmitoylated samples, while the gray top segment shows non-palmitoylated samples.
TCGA Cysteine Mutation Information
Note: Mutations indicate amino acid changes that may create potential palmitoylation sites.
| Position | Amino Acid Change | Frequency | Type | Function | Cancer Type |
|---|---|---|---|---|---|
| 438 | F → C | 0.001887 | SNP | Missense Mutation | UCEC |
| 456 | G → C | 0.001764 | SNP | Missense Mutation | LUAD |
| 480 | R → C | 0.001887 | SNP | Missense Mutation | UCEC |